Cadence Capital Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-19,328
Closed -$1.06M 409
2020
Q2
$1.06M Buy
19,328
+813
+4% +$46.5K 0.15% 206
2020
Q1
$968K Sell
18,515
-964
-5% -$52.2K 0.16% 198
2019
Q4
$948K Sell
19,479
-30,094
-61% -$1.41M 0.1% 276
2019
Q3
$2.72M Buy
49,573
+741
+2% +$42.4K 0.39% 74
2019
Q2
$2.44M Sell
48,832
-1,630
-3% -$81.1K 0.24% 125
2019
Q1
$2.85M Buy
50,462
+14,854
+42% +$885K 0.26% 103
2018
Q4
$2.27M Buy
35,608
+2,775
+8% +$197K 0.23% 125
2018
Q3
$2.67M Sell
32,833
-18,811
-36% -$1.38M 0.14% 186
2018
Q2
$3.3M Buy
51,644
+5,395
+12% +$265K 0.2% 123
2018
Q1
$1.79M Buy
46,249
+24,569
+113% +$861K 0.12% 226
2017
Q4
$608K Sell
21,680
-38,044
-64% -$1.11M 0.04% 463
2017
Q3
$1.6M Buy
59,724
+45,774
+328% +$874K 0.1% 254
2017
Q2
$210K Buy
+13,950
New +$188K 0.01% 644

Other funds holding TRHC

Cadence Capital Management's TRHC Position: Q3 2020 in Review

Cadence Capital Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2020, closing a stake of 19,328 shares — an estimated $1.06M sold.

Cadence Capital Management first reported a position in TRHC in Q2 2017 and held it in 13 quarters. The position peaked at $3.3M in Q2 2018. 160 funds tracked by Wall St. Rank hold TRHC as of Q3 2020.

  • Cadence Capital Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Cadence Capital Management sold 19,328 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2020, an estimated $1.06M.
  • Cadence Capital Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2017 and held it in 13 quarters.
  • Cadence Capital Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $3.3M in Q2 2018.
  • 160 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.